- Home
- CISO vs TPST Comparison
CISO vs TPST Comparison
Compare CISO & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- TPST
- Stock Information
- Founded
- CISO 2015
- TPST 2011
- Country
- CISO United States
- TPST United States
- Employees
- CISO N/A
- TPST N/A
- Industry
- CISO Computer Software: Prepackaged Software
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- TPST Health Care
- Exchange
- CISO Nasdaq
- TPST Nasdaq
- Market Cap
- CISO 31.4M
- TPST 33.0M
- IPO Year
- CISO N/A
- TPST N/A
- Fundamental
- Price
- CISO $1.08
- TPST $6.31
- Analyst Decision
- CISO
- TPST Hold
- Analyst Count
- CISO 0
- TPST 3
- Target Price
- CISO N/A
- TPST $30.00
- AVG Volume (30 Days)
- CISO 963.0K
- TPST 70.7K
- Earning Date
- CISO 08-13-2025
- TPST 08-07-2025
- Dividend Yield
- CISO N/A
- TPST N/A
- EPS Growth
- CISO N/A
- TPST N/A
- EPS
- CISO N/A
- TPST N/A
- Revenue
- CISO $29,887,603.00
- TPST N/A
- Revenue This Year
- CISO N/A
- TPST N/A
- Revenue Next Year
- CISO N/A
- TPST N/A
- P/E Ratio
- CISO N/A
- TPST N/A
- Revenue Growth
- CISO N/A
- TPST N/A
- 52 Week Low
- CISO $0.26
- TPST $5.35
- 52 Week High
- CISO $3.84
- TPST $28.34
- Technical
- Relative Strength Index (RSI)
- CISO 47.60
- TPST 42.85
- Support Level
- CISO $0.97
- TPST $6.57
- Resistance Level
- CISO $1.19
- TPST $6.80
- Average True Range (ATR)
- CISO 0.08
- TPST 0.25
- MACD
- CISO -0.01
- TPST -0.06
- Stochastic Oscillator
- CISO 38.41
- TPST 10.33
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.